Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sorafenib Restores Pentose Phosphate Pathway-Related Redox Homeostasis via the c-Raf/HSP90/G6PD Axis in Hepatic Ischemia-Reperfusion Injury.

MedComm·2026
Same author

An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression.

Biomaterials science·2026
Same author

Localized Depletion of Macrophages by Abdominal Cavity Retention Nanoparticles as a Potential Therapy for Peritoneal Metastasis.

ACS nano·2026
Same author

Mitochondria and Liver Cancer.

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae·2026
Same author

A Tandem-Responsive and Multifunctional Dendritic Dot for Acid and γ-Glutamyl Transpeptidase-Activated Cancer Theranostics.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Bridging hydrogen-bond-stabilized polymeric coacervate core micelles for high-efficiency drug encapsulation and delivery.

Nature communications·2026

Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.6K

Tumor Abnormality-Oriented Nanomedicine Design.

Quan Zhou1,2,3, Jiajia Xiang1,2,3, Nasha Qiu1,2

  • 1Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.

Chemical Reviews
|September 15, 2023
PubMed
Summary
This summary is machine-generated.

Stimuli-responsive nanomedicines leverage tumor microenvironment (TME) abnormalities to improve cancer treatment efficacy and reduce side effects. This review details their design principles and clinical translation challenges.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.2K

Related Experiment Videos

Last Updated: Jul 16, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.6K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

8.2K

Area of Science:

  • Oncology
  • Nanomedicine
  • Biomedical Engineering

Background:

  • Anticancer nanomedicines offer improved side effect profiles compared to traditional chemotherapy.
  • Enhancing the therapeutic efficacy of nanomedicines remains a significant challenge in cancer treatment.
  • Stimuli-responsive nanomedicines are being developed to overcome biological limitations by targeting tumor microenvironment (TME) abnormalities.

Purpose of the Study:

  • To quantify pathological abnormalities within the TME that can act as endogenous stimuli for nanomedicine design.
  • To provide a comprehensive overview of current knowledge on stimuli-responsive nanomedicines for cancer therapy.
  • To discuss strategies for designing nanomedicines that address drug delivery barriers.

Main Methods:

  • Review and analysis of existing literature on TME pathological abnormalities and stimuli-responsive nanomedicines.
  • Dissection of cancer drug delivery processes and associated barriers.
  • Discussion of design principles for stimuli-responsive nanomedicines and integration strategies ('all-into-one', 'one-for-all').

Main Results:

  • Identification of TME pathological abnormalities as potential triggers for targeted nanomedicine activation.
  • Elucidation of key design considerations for overcoming drug delivery challenges using stimuli-responsive systems.
  • Exploration of integrated strategies for developing advanced nanomedicines.

Conclusions:

  • Stimuli-responsive nanomedicines hold significant promise for enhancing cancer therapeutic efficacy and reducing side effects.
  • Understanding and exploiting TME abnormalities are crucial for designing effective nanomedicine platforms.
  • Further research and development are needed to address challenges in the clinical translation of these advanced nanomedicines.